Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
AMGN US​

Amgen Inc(AMGN US)

$439.26-8.021.79%Ext:$440.44+1.180.27%(Market Closed · 23:47:20 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

SEC Filings

Financials(135)

Expand
  • 10-QQ2ended 30 Jun 20264 Aug
  • 10-QQ1ended 31 Mar 202630 Apr
  • 10-KFY 2025ended 31 Dec 202513 Feb
  • 10-QQ3ended 30 Sept 20254 Nov 2025
  • 10-QQ2ended 30 Jun 20256 Aug 2025
  • 10-QQ1ended 31 Mar 20252 May 2025
  • 10-KFY 2024ended 31 Dec 202414 Feb 2025
  • 10-QQ3ended 30 Sept 202431 Oct 2024
  • 10-QQ2ended 30 Jun 20247 Aug 2024
  • 10-QQ1ended 31 Mar 20243 May 2024
  • 10-KFY 2023ended 31 Dec 202314 Feb 2024
  • 10-QQ3ended 30 Sept 202331 Oct 2023
  • 10-QQ2ended 30 Jun 20234 Aug 2023
  • 10-QQ1ended 31 Mar 202328 Apr 2023
  • 10-KFY 2022ended 31 Dec 20229 Feb 2023

Events(324)

Expand
  • 8-KEARNINGS RELEASE4 Aug
  • 8-K<ITEMS>1.0531 Jul
  • 8-KSubmission of Matters to a Vote of Security Holders20 May
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers19 May
  • 8-KEARNINGS RELEASE30 Apr
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers22 Apr
  • 8-KEntry into a Material Definitive Agreement19 Feb
  • 8-KEARNINGS RELEASE3 Feb
  • 8-KTermination of a Material Definitive Agreement30 Jan
  • 8-KEARNINGS RELEASE4 Nov 2025
  • 8-KEARNINGS RELEASE5 Aug 2025
  • 8-KSubmission of Matters to Shareholder Vote27 May 2025
  • 8-KEARNINGS RELEASE1 May 2025
  • 8-KEARNINGS RELEASE4 Feb 2025
  • 8-KAMGN-2024.9.30 EARNINGS RELEASE30 Oct 2024

Insider Ownership(2K)

Expand
  • 3Dittrich Thomas J.W.4 Sep
  • 4Khosla Rachna13 Aug
  • 4Busch Matthew C.12 Aug
  • 4ISHRAK OMAR10 Aug
  • 4HOLLEY CHARLES M10 Aug
  • 4Drake Michael V10 Aug
  • 4Miller Derek7 Aug
  • 4Grygiel Nancy A.7 Aug
  • 4MILES AMY E21 May
  • 4Kullman Ellen Jamison21 May
  • 4Klotman Mary E.21 May
  • 4Jacks Tyler21 May
  • 4ISHRAK OMAR21 May
  • 4HOLLEY CHARLES M21 May
  • 4Garland Greg C.21 May

Beneficial Ownership(123)

Expand
  • SC 13GAMGEN INC14 May
  • SC 13GAMGEN INC29 Apr
  • SC 13G/AAMGEN INC26 Mar
  • SC 13G/AAMGEN INC8 Sep 2025
  • SC 13G/AAMGEN INC17 Apr 2025
  • SC 13G/ANewAmsterdam Pharma Co N.V.23 Aug 2024
  • SC 13G/AAMGEN INC13 Feb 2024
  • SC 13G/AAMGEN INC30 Jan 2024
  • SC 13G/AAMGEN INC25 Jan 2024
  • SC 13DNeumora Therapeutics, Inc.27 Sep 2023
  • SC 13G/AJasper Therapeutics, Inc.10 Feb 2023
  • SC 13G/AAMGEN INC9 Feb 2023
  • SC 13G/AAMGEN INC7 Feb 2023
  • SC 13G/AAMGEN INC6 Feb 2023
  • SC 13GNewAmsterdam Pharma Co N.V.2 Dec 2022

Other Ownership(85)

Expand
  • 144Khosla Rachna13 Aug
  • 144Khosla Rachna11 Aug
  • 144Miller Derek6 Aug
  • 144/AGrygiel Nancy A.6 Aug
  • 144Grygiel Nancy A.6 Aug
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)11 Jun
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)11 Jun
  • 144Grygiel Nancy A.4 May
  • 144Santos Esteban27 Feb
  • 144Busch Matthew C.19 Feb
  • 144Grygiel Nancy A.20 Nov 2025
  • 144Gordon Murdo12 Nov 2025
  • 144Khosla Rachna12 Nov 2025
  • 144Grygiel Nancy A.20 Aug 2025
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)12 Jun 2025

Proxies(134)

Expand
  • DEFA14ADefinitive additional materials21 Apr
  • DEFA14ADefinitive additional materials15 Apr
  • DEFA14ADefinitive additional materials7 Apr
  • DEF 14ADefinitive proxy statement7 Apr
  • ARSAnnual report to security holders31 Mar
  • DEFA14ADefinitive additional materials29 Apr 2025
  • DEFA14ADefinitive additional materials17 Apr 2025
  • PX14A6GNotice of exempt solicitation16 Apr 2025
  • DEF 14ADefinitive proxy statement9 Apr 2025
  • DEFA14ADefinitive additional materials9 Apr 2025
  • ARSAnnual report to security holders2 Apr 2025
  • DEFA14ADefinitive additional materials10 May 2024
  • DEFA14ADefinitive additional materials3 May 2024
  • DEFA14ADefinitive additional materials26 Apr 2024
  • DEFA14ADefinitive additional materials17 Apr 2024

Registrations(250)

Expand
  • 25-NSENotification of removal from listing24 Feb
  • 424B2Prospectus filing (Rule 424(b)(2))18 Feb
  • FWPFree writing prospectus17 Feb
  • 424B3Prospectus filing (Rule 424(b)(3))17 Feb
  • S-3ASRAutomatic shelf registration statement (S-3)13 Feb
  • S-8Registration statement (employee benefit plan)12 Jun 2024
  • S-8Registration statement (employee benefit plan)6 Oct 2023
  • 424B2Prospectus filing (Rule 424(b)(2))17 Feb 2023
  • FWPFree writing prospectus16 Feb 2023
  • 424B3Prospectus filing (Rule 424(b)(3))14 Feb 2023
  • S-3ASRAutomatic shelf registration statement (S-3)9 Feb 2023
  • 424B2Prospectus filing (Rule 424(b)(2))16 Aug 2022
  • 424B3Prospectus filing (Rule 424(b)(3))15 Aug 2022
  • FWPFree writing prospectus15 Aug 2022
  • 424B2Prospectus filing (Rule 424(b)(2))18 Feb 2022

Filing Review Correspondence(12)

Expand
  • CORRESPFiling review correspondence22 Apr 2024
  • CORRESPFiling review correspondence13 Apr 2021
  • CORRESPFiling review correspondence9 Feb 2021
  • CORRESPFiling review correspondence7 Dec 2016
  • UPLOADFiling review upload10 Apr 2009
  • CORRESPFiling review correspondence1 Apr 2009
  • UPLOADFiling review upload24 Mar 2009
  • UPLOADFiling review upload30 Aug 2006
  • CORRESPFiling review correspondence27 Jul 2006
  • CORRESPFiling review correspondence9 Jun 2006
  • UPLOADFiling review upload25 May 2006
  • UPLOADFiling review upload6 Feb 2006

SEC Orders And Notices(36)

Expand
  • EFFECTNotice of effectiveness15 Apr 2021
  • CT ORDERConfidential treatment order24 Oct 2019
  • CT ORDERConfidential treatment order3 Jun 2019
  • CT ORDERConfidential treatment order30 May 2018
  • CT ORDERConfidential treatment order17 May 2018
  • CT ORDERConfidential treatment order4 Dec 2017
  • CT ORDERConfidential treatment order8 Sep 2017
  • CT ORDERConfidential treatment order15 Aug 2017
  • CT ORDERConfidential treatment order26 May 2017
  • CT ORDERConfidential treatment order8 May 2017
  • CT ORDERConfidential treatment order6 Mar 2017
  • EFFECTNotice of effectiveness9 Dec 2016
  • CT ORDERConfidential treatment order23 Apr 2015
  • EFFECTNotice of effectiveness18 Dec 2014
  • EFFECTNotice of effectiveness18 Dec 2014

Tender Offers And Going Private(77)

Expand
  • SC TO-T/ATender offer statement (third-party, amendment)16 Apr 2021
  • SC TO-T/ATender offer statement (third-party, amendment)8 Apr 2021
  • SC TO-T/ATender offer statement (third-party, amendment)6 Apr 2021
  • SC TO-T/ATender offer statement (third-party, amendment)22 Mar 2021
  • SC TO-TTender offer statement (third-party)18 Mar 2021
  • SC TO-CTender offer statement (communication)5 Mar 2021
  • SC TO-CTender offer statement (communication)4 Mar 2021
  • SC TO-CTender offer statement (communication)4 Mar 2021
  • SC TO-I/ATender offer statement (issuer, amendment)8 Mar 2018
  • SC TO-I/ATender offer statement (issuer, amendment)6 Mar 2018
  • SC TO-I/ATender offer statement (issuer, amendment)26 Feb 2018
  • SC TO-I/ATender offer statement (issuer, amendment)23 Feb 2018
  • SC TO-I/ATender offer statement (issuer, amendment)20 Feb 2018
  • SC TO-I/ATender offer statement (issuer, amendment)14 Feb 2018
  • SC TO-I/ASCHEDULE TO-I/A (AMENDMENT NO. 1)5 Feb 2018

Exempt Offerings(5)

Expand
  • D/A06b23 Jan 2015
  • D/A06b29 Jan 2014
  • D/ANotice of exempt offering of securities (Reg D, amendment)4 Feb 2013
  • D/ANotice of exempt offering of securities (Reg D, amendment)29 Feb 2012
  • DNotice of exempt offering of securities (Reg D)14 Mar 2011

Other(12)

Expand
  • 252528 Dec 2020
  • CERTCERT28 Dec 2020
  • NO ACTAUTO-GENERATED PAPER DOCUMENT10 Feb 2017
  • SDSD31 May 2016
  • CERTNYSAUTO-GENERATED PAPER DOCUMENT1 Mar 2016
  • NO ACTAUTO-GENERATED PAPER DOCUMENT25 Jan 2012
  • NO ACTAUTO-GENERATED PAPER DOCUMENT17 Feb 2011
  • NO ACTAUTO-GENERATED PAPER DOCUMENT3 Mar 2009
  • NO ACTAUTO-GENERATED PAPER DOCUMENT26 Jan 2005
  • NO ACTAUTO-GENERATED PAPER DOCUMENT10 Feb 2004
  • NO ACTAUTO-GENERATED PAPER DOCUMENT12 Jan 2004
  • 10-K40510-K4057 Mar 2000

Financials & Metrics

FinancialsChartingShort InterestEmployees